% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hermann:169347,
author = {Hermann, Peter and Schmitz, Matthias and Cramm, Maria and
Goebel, Stefan and Bunck, Timothy and Schütte-Schmidt,
Julia and Schulz-Schaeffer, Walter and Stadelmann, Christine
and Matschke, Jakob and Glatzel, Markus and Zerr, Inga},
title = {{A}pplication of real-time quaking-induced conversion in
{C}reutzfeldt-{J}akob disease surveillance.},
journal = {Journal of neurology},
volume = {270},
number = {4},
issn = {0340-5354},
address = {Berlin},
publisher = {Springer},
reportid = {DZNE-2023-00122},
pages = {2149-2161},
year = {2023},
note = {ISSN 1432-1459 not unique: **2 hits**.},
abstract = {Evaluation of the application of CSF real-time
quaking-induced conversion in Creutzfeldt-Jakob disease
surveillance to investigate test accuracy, influencing
factors, and associations with disease incidence.In a
prospective surveillance study, CSF real-time
quaking-induced conversion was performed in patients with
clinical suspicion of prion disease (2014-2022). Clinically
or histochemically characterized patients with sporadic
Creutzfeldt-Jakob disease (n = 888) and patients with final
diagnosis of non-prion disease (n = 371) were included for
accuracy and association studies.The overall test
sensitivity for sporadic Creutzfeldt-Jakob disease was
$90\%$ and the specificity $99\%.$ Lower sensitivity was
associated with early disease stage (p = 0.029) and longer
survival (p < 0.001). The frequency of false positives was
significantly higher in patients with inflammatory CNS
diseases $(3.7\%)$ than in other diagnoses $(0.4\%,$ p =
0.027). The incidence increased from 1.7 per million
person-years (2006-2017) to 2.0 after the test was added to
diagnostic the criteria (2018-2021).We validated high
diagnostic accuracy of CSF real-time quaking-induced
conversion but identified inflammatory brain disease as a
potential source of (rare) false-positive results,
indicating thorough consideration of this condition in the
differential diagnosis of Creutzfeldt-Jakob disease. The
surveillance improved after amendment of the diagnostic
criteria, whereas the incidence showed no suggestive
alterations during the COVID-19 pandemic.},
keywords = {Humans / Creutzfeldt-Jakob Syndrome: diagnosis /
Creutzfeldt-Jakob Syndrome: epidemiology / Prospective
Studies / Pandemics / Sensitivity and Specificity / COVID-19
/ Creutzfeldt–Jakob disease (Other) / Creutzfeldt–Jakob
disease (Other) / Diagnosis (Other) / Epidemiology (Other) /
Prion (Other) / RT-QuIC (Other)},
cin = {AG Zerr / Ext UMG Zerr},
ddc = {610},
cid = {I:(DE-2719)1440011-1 / I:(DE-2719)5000037},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36624183},
pmc = {pmc:PMC9829526},
doi = {10.1007/s00415-022-11549-2},
url = {https://pub.dzne.de/record/169347},
}